Optimal Tracers - About the company
Optimal Tracers is an acquired company based in Sacramento (United States), founded in 2013. It operates as a CRO focused on clinical research and tracer development services. The company has 8 active competitors, including 2 funded and 2 that have exited. Its top competitors include companies like Lexitas, Eyecro and Humonix Biosciences.
Company Details
- Website
- optimaltracers.org
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
Sacramento, United States
Stage
Acquired
Ranked
5th among 8 active competitors
Employee Count
3 as on Apr 30, 2026
Exit Details
Acquired by Telix Pharma (Nov 13, 2022)
Optimal Tracers's acquisition details
Optimal Tracers got acquired by Telix Pharma on Nov 13, 2022.
Click here to take a look at Optimal Tracers's acquisition in detail
Sign up to download Optimal Tracers' company profile
Optimal Tracers's funding and investors
Optimal Tracers has not raised any funding rounds yet.
Optimal Tracers' founders and board of directors
Founder? Claim ProfileOptimal Tracers' employee count trend
Optimal Tracers has 3 employees as of Apr 26. Here is Optimal Tracers's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Optimal Tracers's Competitors and alternates
Top competitors of Optimal Tracers include Lexitas, Eyecro and Humonix Biosciences. Here is the list of Top 10 competitors of Optimal Tracers, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lexitas 2011, Durham (United States), Acquired | Provider of clinical trial and medical strategy services for developing ophthalmology products | - | - | 46/100 |
2nd | Eyecro 2005, Oklahoma City (United States), Funding Raised | Preclinical ophthalmic research leader, specializing in novel test agents and therapeutic modalities | - | 35/100 | |
3rd | Humonix Biosciences 2014, Albany (United States), Seed | CRO focused on ophthalmic drugs development services | $250K | 29/100 | |
4th | Experimentica 2013, Kuopio (Finland), Funding Raised | Developing in vitro, ex vivo and in vivo preclinical ocular models | - | 28/100 | |
5th | Optimal Tracers 2013, Sacramento (United States), Acquired | CRO focused on clinical research and tracer development services | - | - | 23/100 |
6th | Aufbau Holdings 2019, Dublin (Ireland), Series A | Developer of diagnostic and therapeutic platforms for cancer and eye diseases | $6.1M | - | 22/100 |
7th | Rudacure 2018, Incheon (South Korea), Unfunded | Developer of Rac1 inhibitors for treating ocular surface diseases | - | - | 18/100 |
8th | VO-CRO 1995, Nashville (United States), Unfunded | CRO focused on preclinical studies of ophthalmic diseases | - | - | 18/100 |
9th | Ophthy-DS 2009, Michigan City (United States), Deadpooled | Provider of preclinical services for drug development | - | - | 17/100 |
10th | ImmunEyez 2015, Georgetown (United States), Deadpooled | Provider of preclinical research services | - | - | 16/100 |
Looking for more details on Optimal Tracers's competitors? Click here to see the top ones
Optimal Tracers's Investments and acquisitions
Optimal Tracers has made no investments or acquisitions yet.
News related to Optimal Tracers
•
•
Australian company Telix Pharmaceuticals to acquire Sacramento company Optimal TracersThe Business Journals•Nov 17, 2022•Telix Pharma, Optimal Tracers
•
Telix Acquires Optimal TracersPR Newswire•Nov 14, 2022•Telix Pharma, Optimal Tracers, Northern California PET Imaging Center
Are you a Founder ?
FAQs about Optimal Tracers
Explore our recently published companies
- Pie-Tech - 2007 founded, Unfunded company
- Commspartner - Unfunded company
- Sherpa Consulting - Woodside based, 2016 founded, Unfunded company
- Techlan - Unfunded company
- Techtactics - Unfunded company
- Mccombinc - 2001 founded, Unfunded company
